SEC Form 4 · accession 0001493152-26-043910
InspireMD, Inc. · NSPR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Paul Stuka
Director
Period of report
Sep 21, 2026
Accepted (ET)
Sep 23, 2026 · 4:05 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001433607
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Series J Warrant (right to buy)F3,F2 | $1.3827 | Sep 18, 2026 | J | 43,750 | D | May 15, 2023 | — | Common Stock | 43,750 | 43,750 | I |
| Series J Warrant (right to buy)F3,F4 | $0.7674 | Sep 18, 2026 | J | 43,750 | A | May 15, 2023 | — | Common Stock | 43,750 | 43,750 | I |
| Series K Warrant (right to buy)F3,F6 | $1.3827 | Sep 18, 2026 | J | 87,500 | D | May 15, 2023 | — | Common Stock | 87,500 | 0 | I |
| Series K Warrant (right to buy)F3,F7 | $0.7674 | Sep 18, 2026 | J | 87,500 | A | May 15, 2023 | — | Common Stock | 87,500 | 43,750 | I |
Explanation of responses
- F1See Exhibit 99.1; Note 1
- F2See Exhibit 99.1; Note 2
- F3See Exhibit 99.1; Note 3
- F4See Exhibit 99.1; Note 4
- F5See Exhibit 99.1; Note 5
- F6See Exhibit 99.1; Note 6
- F7See Exhibit 99.1; Note 7